To address this possibility, we induced the mouse NAFLD model by HFD; the serum ALT level was increased in the NAFLD group (Figure 1B), and the AST level remained unaffected compared with the non-NAFLD group (Figure 1C). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.